Clinical Trial: Schistosoma Haematobium Infections and Praziquantel

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: Schistosoma Haematobium Infections Among Schoolchildren in Central Sudan One Year After Treatment With Praziquantel

Brief Summary: The purpose of this study is to evaluate the impact of praziquantel for the treatment of Schistosoma haematobium infection among schoolchildren in Al Salamania in Central Sudan.

Detailed Summary: A longitudinal study will be conducted to evaluate the impact of praziquantel for the treatment of Schistosoma haematobium infection among schoolchildren in Al Salamania in Central Sudan. A cohort of schoolchildren (6-15 years of age) was investigated before and 1 year after treatment with a single dose of praziquantel 40mg/kg.
Sponsor: University of Khartoum

Current Primary Outcome: cure rate [ Time Frame: one year ]

The reduction of the prevalence and intensity of S.haematobium infection following a single dose of praziquantel40mg/kg


Original Primary Outcome: Same as current

Current Secondary Outcome: reduction in the intensity of infection by [ Time Frame: one year ]

will a single dose of PZQ significantly reduced intensity of infection of S. haematobium infection 1 year after treatment


Original Secondary Outcome: Same as current

Information By: University of Khartoum

Dates:
Date Received: March 16, 2012
Date Started: August 2008
Date Completion:
Last Updated: January 16, 2013
Last Verified: January 2013